Quarterly Report I 11/12
Quarterly Report Diamyd Medical AB (publ), fiscal year 2011/2012(www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY)Reporting period September 1, 2011 – November 30, 2011- Group total net sales amounted to MSEK 0.1 (144.5)- Profit before tax amounted to MSEK -7.4 (98.3)- Earnings per share after dilution were SEK -0.26 (3.32)- The Group’s liquid assets amounted to MSEK 414 (478) as of November 30, 2011Significant events during the reporting period- Diamyd Medical was awarded a USD three million grant and expanded the NTDDS portfolio- University of
